Pharma plays are always the target of MM short attack after good news. Even an FDA 501 approval. You have to be fast on your feet till the drug is sold, bought out or shows it's going to be a block buster $ maker. Even after a 501 it still needs to show it has market potential.
I'd imagine this will get bought out by a Big Pharma before its gets too high. Depression is a $ maker.